loading
Display Results in "Google-style" View  
 
 

(2009.10) LONZA PRESENTS NEW IMMUNOMODULATORY RESEARCH RESULTS FOR (LAG)-BASED RESISTAID™

Article
Lonza Inc. Press Release: A new study sponsored by Lonza demonstrated a positive immune response by the Larch Arabinogalactan (LAG)-based ResistAid™. Pre-sented at the 50th Annual Meeting of the American College of Nutrition in Orlando, Flor-ida, the results of the randomized, double-blind, placebo-controlled, parallel-group study showed that ResistAid™ increased the antibody (Ab) response to the 23-valent pneu-mococcal (pneumonia) vaccine.
 

(2010.02) LONZA PRESENTS THE LATEST NUTRITIONAL BARS WITH CARNIPURE™

Article
Lonza Inc. Press Release: Lonza recently presented the newest nutritional bars containing Carnipure™, its branded L-Carnitine health ingredient, at the third annual Healthy & Nutritional Bars Conference in Cologne, Germany.
 

(2010.02) LONZA’S RESISTAID™ PROVIDES IMMUNE SYSTEM BENEFITS

Article
Lonza Inc. Press Release: Lonza is pleased to announce the inclusion of its Larch Arabinogalactan (LAG)-based ResistAid™ in Ultimate Flora Advanced Immunity™, from ReNew Life.
 

RESISTAID™ - POSTER STUDY

Article
Lonza Inc. IMMUNOMODULATORY EFFECTS OF A PROPRIETARY ARABINOGALACTAN EXTRACT
 
1